Sleepiness in Parkinson's disease (Q43190971)

15 November 2017

Sleepiness in Parkinson's disease (English)

1 reference

15 November 2017

1 reference

1

1 reference

15 November 2017

Smaranda Leu-Semenescu

series ordinal

2

1 reference

15 November 2017

1 December 2009

1 reference

Parkinsonism and Related Disorders

15 November 2017

1 reference

15 November 2017

15 Suppl 3

1 reference

15 November 2017

S101-4

1 reference

Parkinson's disease and driving ability.

15 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the epworth sleepiness scale: failure of the MSLT as a gold standard

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Daytime sleepiness and other sleep disorders in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Evaluation of somnolence in Parkinson's disease: comparison with age- and sex-matched controls.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Development of daytime somnolence over time in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Excessive daytime sleepiness and subsequent development of Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Predictors of sudden onset of sleep in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Parkinson's disease and sleepiness: an integral part of PD.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Unawareness of naps in Parkinson’s disease and in disorders with excessive daytime sleepiness

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

FAST TRACK: daytime sleepiness in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Restoration of normal motor control in Parkinson's disease during REM sleep.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

The substantia nigra of the human brain. II. Patterns of loss of dopamine-containing neurons in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Brain histidine decarboxylase activity in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Hypocretin (orexin) loss in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Hypocretin (orexin) cell loss in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Sudden uncontrollable somnolence and medication use in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Efficacy of pramipexole and transdermal rotigotine in advanced Parkinson's disease: a double-blind, double-dummy, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Efficacy and safety of pramipexole in restless legs syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Excessive daytime somnolence in Parkinson's disease. Follow-up after 1 year of treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Bidirectional dopaminergic modulation of excitatory synaptic transmission in orexin neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Antiparkinsonian and neuroprotective effects of modafinil in the mptp-treated common marmoset

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-/- mice and patients

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Pedunculopontine nucleus stimulation influences REM sleep in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Selective enhancement of rapid eye movement sleep by deep brain stimulation of the human pons.

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

Hypothalamic regulation of sleep and circadian rhythms

1 reference

https://api.crossref.org/works/10.1016%2FS1353-8020%2809%2970792-8

7 January 2021

10.1016/S1353-8020(09)70792-8

Identifiers

DOI

1 reference

15 November 2017

1 reference

PubMed ID

20082966